Company Profiles

driven by the PitchBook Platform

t-cell Europe

Description

Provider of kidney transplantation services. The company develops and commercializes T-cell-based therapies for kidney transplants to prevent immune system overreactions.

2010

Founded

PRIVATE

Status

1-10

Employees

Series A

Latest Deal Type

$1.86M

Latest Deal Amount

$1.86M

Total Amount Raised

Description

Provider of kidney transplantation services. The company develops and commercializes T-cell-based therapies for kidney transplants to prevent immune system overreactions.

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Other Healthcare Services

Other Industries

Other Pharmaceuticals and Biotechnology

Primary Office

Jägerallee 37i 14471 PotsdamGermany +49 (0)33 1279 7569 0
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore t-cell Europe's full profile, request a free trial.

    t-cell Europe Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    t-cell Europe Investors (3)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Constantin Bastian Leander Venture CapitalVenture CapitalMinority000 0000000 0000
    High-Tech GründerfondsVenture CapitalMinority000 0000000 0000
    Investitionsbank des Landes BrandenburgOtherMinority000 0000000 0000
    Constantin Bastian Leander Venture Capital Venture Capital
    High-Tech Gründerfonds Venture Capital
    Investitionsbank des Landes Brandenburg Other

    t-cell Europe Executive Team (2)

    NameTitleBoard
    Seat
    Contact
    Info
    Hans-Deiter VolkChief Scientific Advisor
    Petra ReinkeChief Clinical Advisor
    Hans-Deiter Volk Chief Scientific Advisor
    Petra Reinke Chief Clinical Advisor
    Request full access to PitchBook